Angiotensin-Converting Enzyme: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 85: | Line 85: | ||
**[[2ydm]] - hANCE + captopril analog<br /> | **[[2ydm]] - hANCE + captopril analog<br /> | ||
**[[3kbh]], [[3d0g]], [[3d0h]], [[3d0i]], [[2ajf]], [[3sci]], [[3scj]], [[3sck]], [[3scl]] – hANCE 2 fragment+spike glycoprotein<br /> | **[[3kbh]], [[3d0g]], [[3d0h]], [[3d0i]], [[2ajf]], [[3sci]], [[3scj]], [[3sck]], [[3scl]] – hANCE 2 fragment+spike glycoprotein<br /> | ||
**[3l3n]] – hANCE+LISW<br /> | **[[3l3n]] – hANCE+LISW<br /> | ||
**[[3bkk]], [[3bkl]] – hANCE+ketone inhibitor<br /> | **[[3bkk]], [[3bkl]] – hANCE+ketone inhibitor<br /> | ||
**[[2oc2]], [[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]] - hANCE+phosphinic inhibitor<br /> | **[[2oc2]], [[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]] - hANCE+phosphinic inhibitor<br /> | ||
| Line 94: | Line 94: | ||
**[[4apj]] – hANCE + bradykinin-potentiating peptide B<br /> | **[[4apj]] – hANCE + bradykinin-potentiating peptide B<br /> | ||
**[[1r42]], [[1r4l]] – hANCE + disordered segment of collectrin homology domain<br /> | **[[1r42]], [[1r4l]] – hANCE + disordered segment of collectrin homology domain<br /> | ||
**[[4bzr]] - hANCE+K26<br /> | |||
**[[4bzs]] – hANCE (mutant) +K26<br /> | |||
**[[2xhm]] – DmANCE+K26 <br /> | **[[2xhm]] – DmANCE+K26 <br /> | ||
**[[2x8z]], [[2x90]], [[2x91]], [[2x92]], [[2x93]], [[2x94]], [[2x95]], [[2x96]], [[2x97]], [[1j36]], [[1j37]], [[1j38]] – DmANCE+anti-hypertensive drug<br /> | **[[2x8z]], [[2x90]], [[2x91]], [[2x92]], [[2x93]], [[2x94]], [[2x95]], [[2x96]], [[2x97]], [[1j36]], [[1j37]], [[1j38]] – DmANCE+anti-hypertensive drug<br /> | ||
